Are you looking for a Thanksgiving health story? Consider adding the brewing “tripledemic” of pathogens to your coverage. Respiratory syncytial virus (RSV), influenza and SARS-CoV-2, the virus that causes COVID-19, are overwhelming hospitals, and some health care experts are urging families to bring back some of the pandemic’s mitigation measures during the holiday.
In the coming year, more clues are expected to emerge to help unravel the mystery of long COVID as dozens of global study results are released.
To help you with your coverage of the evolving understanding of long COVID, we have created a tip sheet in a Q&A format to help explain what is known, as of October 2022, about long COVID and to provide resources for covering this topic.
It may seem a bit like the boy who cried wolf, but public health officials are once again urging the public to be concerned about a “twindemic” of COVID-19 and flu this coming winter.
The reason: A combination of a tough flu season in the southern hemisphere, the end of pandemic social distancing and masking behaviors, and the potential for another SARS-CoV-2 variant, experts say.
The number of new monkeypox cases has declined since this summer, but many questions remain about symptoms, transmission, vaccines, treatments and whether the virus that causes the disease can mutate.
For health journalists covering the evolving monkeypox story, AHCJ’s webinar on Sept. 22 at noon EST provides a great opportunity to get answers to some of your questions by asking White House National Monkeypox Response Deputy Coordinator Demetre Daskalakis, M.D, M.P.H.
Journalists should check in on how the U.S. government and the nation’s hospitals and medical practices intend to regain ground lost during the pandemic in the battle against superbugs. These pathogens have evolved to resist most existing antimicrobial medications, like antibiotics and antifungals.